Skip to main content

RT @doctorRBC: Upadacitinib effective in treatment of ankylosing spondylitis pts refractory to biologic tx - phase 3 tri

Social Author Name
Robert B Chao, MD
Tweet Content
Upadacitinib effective in treatment of ankylosing spondylitis pts refractory to biologic tx - phase 3 trial Primary endpoint (ASAS40) and secondary endpoints met No malignancy, MACE, VTE, death @RheumNow #EULAR2022 ABST#POS0306 https://t.co/UL4hUJ0rQV
Show on Archive Page
On
Display in Search Results
On
PDQ
Off